I was just medling with medical archives to learn more about David Stamler.
He was the chief medical officer of Auspex which got bought by Teva for $3.5B. SD-809 was the lead candidate drug for treating chorea. The drug got FDA approval in 2017
This impeccable record could be the reason Stamler is paid a hefty salary. I will not be surprised if ATH434 walks in the footsteps of SD-809
I will wait until the end. I'm not releasing my shares.
- Forums
- ASX - By Stock
- Ann: Alterity Therapeutics Raises $4.8M AUD in Placement
I was just medling with medical archives to learn more about...
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $4.233K | 885.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
69 | 90514720 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 20531083 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
66 | 90039720 | 0.004 |
50 | 53645564 | 0.003 |
17 | 39293014 | 0.002 |
14 | 93670101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 19830107 | 15 |
0.006 | 34444496 | 18 |
0.007 | 17035413 | 18 |
0.008 | 15410875 | 17 |
0.009 | 6275000 | 7 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
0.5¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.5¢ | 0.5¢ | 500000 | ||
Last updated 15.07pm 14/06/2024 ? |
Featured News
ATH (ASX) Chart |